Area of research
Infectious Diseases · Immunology
Research interest
Research interests include Biology, Virology, Cell biology, Antibody, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and Neutralizing antibody.
A comparative study of in vitro air–liquid interface culture models of the human airway epithelium evaluating cellular heterogeneity and gene expression at single cell resolution
Long noncoding RNA <i>CHROMR</i> regulates antiviral immunity in humans
ACE2-containing defensosomes serve as decoys to inhibit SARS-CoV-2 infection
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates
A Comparative Analysis of SARS-CoV-2 Antivirals Characterizes 3CL <sup>pro</sup> Inhibitor PF-00835231 as a Potential New Treatment for COVID-19
The NSP14/NSP10 RNA repair complex as a Pan-coronavirus therapeutic target
Antibody isotype diversity against SARS-CoV-2 is associated with differential serum neutralization capacities
Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV
Nerve associated lung resident interstitial macrophage subset exhibits distinct localization and polarization
The ETS transcription factor ELF1 regulates a broadly antiviral program distinct from the type I interferon response
A cholesterol consensus motif is required for efficient intracellular transport and raft association of a group 2 HA from influenza virus
Mutation of a raft‐targeting signal in the transmembrane region retards transport of influenza virus hemagglutinin through the Golgi